Trial intelligence / Profile preview

Duloxetine vs nortriptyline for pain in rheumatoid arthritis

IRCT20220901055848N1Phase 3Completed

Sponsor
Shahid Beheshti University of Medical Sciences
Start
Feb 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of duloxetine and nortriptyline in pain and rheumatoid arthritis (RA) (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Started Feb 2023; status: completed.

02

Drugs

duloxetinenortriptyline
03

Conditions

painrheumatoid arthritis (RA)

Beyond the preview

Go deeper on IRCT20220901055848N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20220901055848N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call